Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Justin Walsh's Stock Ratings
Jones Trading Analyst
Justin Walsh is an analyst at Jones Trading. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
16.6%
Smart Score
Overall Average Return Percentile
71st
Number of Ratings
50
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/18/2025 | PRAX | Buy Now | Praxis Precision Medicine | $276.40 | -69.97% | → $83 | Initiates | → Buy | Get Alert | |
| 09/16/2025 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 26.18% | $109 → $84 | Maintains | Buy | Get Alert | |
| 08/05/2025 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 07/03/2025 | THTX | Buy Now | Theratechnologies | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 06/23/2025 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 63.74% | $122 → $109 | Maintains | Buy | Get Alert | |
| 06/10/2025 | VNRX | Buy Now | VolitionRX | — | — | → $3 | Initiates | → Buy | Get Alert | |
| 05/30/2025 | BLRX | Buy Now | BioLine Rx | $3.23 | 271.52% | → $12 | Upgrade | Hold → Buy | Get Alert | |
| 04/23/2025 | CLNN | Buy Now | Clene | $6.36 | 371.7% | → $30 | Initiates | → Buy | Get Alert | |
| 04/02/2025 | MNPR | Buy Now | Monopar Therapeutics | $75.12 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 04/02/2025 | BLRX | Buy Now | BioLine Rx | $3.23 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 03/21/2025 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 83.27% | $127 → $122 | Maintains | Buy | Get Alert | |
| 03/11/2025 | SER | Buy Now | Serina Therapeutics | $2.99 | 267.89% | → $11 | Initiates | → Buy | Get Alert | |
| 12/16/2024 | ANRO | Buy Now | Alto Neuroscience | $18.00 | — | → $18 | Initiates | → Buy | Get Alert | |
| 10/18/2024 | RAPP | Buy Now | Rapport Therapeutics | $29.60 | 41.89% | → $42 | Initiates | → Buy | Get Alert | |
| 10/11/2024 | THTX | Buy Now | Theratechnologies | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 09/04/2024 | BLRX | Buy Now | BioLine Rx | $3.23 | -38.08% | → $2 | Initiates | → Buy | Get Alert | |
| 07/25/2024 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 119.32% | $105 → $146 | Maintains | Buy | Get Alert | |
| 07/19/2024 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 105.8% | $128 → $137 | Maintains | Buy | Get Alert | |
| 07/11/2024 | YMAB | Buy Now | Y-mAbs Therapeutics | — | — | → $23 | Initiates | → Buy | Get Alert | |
| 05/16/2024 | CATX | Buy Now | Perspective Therapeutics | — | — | $1.5 → $2.2 | Maintains | Buy | Get Alert | |
| 05/10/2024 | TLSI | Buy Now | TriSalus Life Sciences | $7.31 | 118.88% | → $16 | Initiates | → Buy | Get Alert | |
| 04/18/2024 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 48.72% | $95 → $99 | Maintains | Buy | Get Alert | |
| 04/17/2024 | ACHV | Buy Now | Achieve Life Sciences | $4.47 | 347.43% | → $20 | Initiates | → Buy | Get Alert | |
| 03/20/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 01/10/2024 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 42.71% | $113 → $95 | Maintains | Buy | Get Alert | |
| 11/15/2023 | CATX | Buy Now | Perspective Therapeutics | — | — | → $1.4 | Initiates | → Buy | Get Alert | |
| 10/04/2023 | PNT | Buy Now | POINT Biopharma Global | — | — | — | Downgrade | Buy → Hold | Get Alert | |
| 10/03/2023 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 69.75% | → $113 | Reiterates | Buy → Buy | Get Alert | |
| 09/07/2023 | CTSO | Buy Now | CytoSorbents | $0.68 | 485.22% | → $4 | Reinstates | Buy → Buy | Get Alert | |
| 09/06/2023 | PRME | Buy Now | Prime Medicine | $4.01 | 398.75% | → $20 | Initiates | → Buy | Get Alert | |
| 07/17/2023 | THTX | Buy Now | Theratechnologies | — | — | $6 → $3 | Maintains | Buy | Get Alert | |
| 05/16/2023 | VOR | Buy Now | Vor Biopharma | $13.27 | 35.64% | → $18 | Initiates | → Buy | Get Alert | |
| 05/11/2023 | VRAY | Buy Now | ViewRay | — | — | $4 → $1 | Downgrade | Buy → Neutral | Get Alert | |
| 03/22/2023 | TFFP | Buy Now | TFF Pharmaceuticals | — | — | → $7 | Initiates | → Buy | Get Alert | |
| 02/10/2023 | MYNZ | Buy Now | Mainz Biomed | $1.02 | 978.43% | → $11 | Initiates | → Buy | Get Alert | |
| 10/07/2022 | PSTV | Buy Now | Plus Therapeutics | $0.63 | 695.42% | → $5 | Initiates | → Buy | Get Alert | |
| 10/07/2022 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 56.23% | → $104 | Initiates | → Buy | Get Alert | |
| 09/07/2022 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | → $10 | Initiates | → Buy | Get Alert | |
| 09/07/2022 | PNT | Buy Now | POINT Biopharma Global | — | — | → $22 | Initiates | → Buy | Get Alert | |
| 05/20/2022 | HROW | Buy Now | Harrow Health | $45.70 | -56.24% | $17 → $20 | Maintains | Buy | Get Alert | |
| 05/09/2022 | LNTH | Buy Now | Lantheus Holdings | $66.57 | 36.7% | → $91 | Initiates | → Buy | Get Alert | |
| 05/04/2022 | CTSO | Buy Now | CytoSorbents | $0.68 | 777.83% | $7 → $6 | Maintains | Buy | Get Alert | |
| 04/05/2022 | CRIS | Buy Now | Curis | $1.21 | 728.09% | $22 → $10 | Maintains | Buy | Get Alert | |
| 01/19/2022 | CMPX | Buy Now | Compass Therapeutics | $5.07 | 97.24% | → $10 | Initiates | → Buy | Get Alert | |
| 01/11/2022 | VRAY | Buy Now | ViewRay | — | — | → $7 | Upgrade | Neutral → Buy | Get Alert | |
| 09/02/2021 | PRTG | Buy Now | Portage Biotech | — | — | → $40 | Initiates | → Buy | Get Alert | |
| 03/25/2021 | VOR | Buy Now | Vor Biopharma | $13.27 | 352.15% | → $60 | Initiates | → Buy | Get Alert | |
| 03/25/2021 | CRIS | Buy Now | Curis | $1.21 | 1473.37% | → $19 | Initiates | → Buy | Get Alert | |
| 05/06/2020 | CTSO | Buy Now | CytoSorbents | $0.68 | 2240.89% | $12 → $16 | Maintains | Buy | Get Alert | |
| 10/07/2016 | CTSO | Buy Now | CytoSorbents | $0.68 | — | — | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved